Post

The cost structure of this technology is the real differentiator at scale.

Servier Laboratories (Suresnes, France). 2024 revenue ~€5.3B. Private pharma. Oncology: Lonsurf, Onureg. Cardiovascular: Coversyl, Corbilian. 22K employees. Non-profit foundation ownership.